News

University College London cancer vaccines spin-out BioVex has been bought by US biotech company Amgen in deal worth up to $1 billion.

The European Patent Organisation has received 10% more applications last year, and expects a further increase in 2011.

Off-label and unauthorised drugs are still being prescribed, according to a European survey on use of medicines for children.

Economic recovery would benefit from greener, private investment encouraging, government policies, according to an academic report.

More R&D investment is needed to increase the world's food supplies, concludes a UK Government Office for Science report.

The Swiss Federal Institute of Technology in Lausanne has just opened the doors to a new national robotics research centre that aims to usher in a new era of robots, designed to do useful things in ordinary circumstances.